Efficacy of Prostate-Specific Antigen to Categorize Men with Prostate Pathology into Benign, Premalignant, and Malignant Lesions
Background: Prostate-specific antigen (PSA) is a widely used biochemical marker for the early detection and monitoring of patients with prostatic cancer. PSA level show ever may vary with patient age, race and may be elevated in conditions such as benign prostatic hyperplasia (BPH) and prostatitis....
Main Authors: | Raja Parthiban, A N Roopa, Kusuma Puttaswamy, Shameem Shariff |
---|---|
Format: | Article |
Language: | English |
Published: |
ADICHUNCHANAGIRI INSTITUTE OF MEDICAL SCIENCES
2016-06-01
|
Series: | Journal of Medical Sciences and Health |
Subjects: | |
Online Access: | http://www.jmsh.ac.in/index.php?option=com_k2&view=item&id=45:efficacy-of-prostate-specific-antigen-to-categorize-men-with-prostate-pathology-into-benign-premalignant-and-malignant-lesions&Itemid=75 |
Similar Items
-
Histopathological Study of Prostatic Biopsies in Men with Prostatism
by: Kusuma Puttaswamy, et al.
Published: (2016-02-01) -
Study of prostatic pathology and its correlation with prostate specific antigen level
by: S Hirachand, et al.
Published: (2017-03-01) -
Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01) -
Recommendations of Test of Prostate-specific Antigen along with Histopathological Examination for the Prostate Lesions
by: Pallavi Gedam, et al.
Published: (2019-10-01) -
Comparison of telomerase activity in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic hyperplasia
by: Soleiman Mahjoub, et al.
Published: (2006-11-01)